Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nikhil I Khushalani, MD
H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- [site 02] Mayo Clinic Arizona
Phoenix, Arizona, United States
- [site 11] University of California, San Diego Medical Center
La Jolla, California, United States
- [site 01] Hematology - Oncology Associates of the Treasure Coast
Port Saint Lucie, Florida, United States
- [site 09] H. Lee Moffitt Cancer Center and Research Institute, Inc.
Tampa, Florida, United States
- [site 13] Frederick Memorial Hospital D/b/a James M Stockman Cancer Institute
Frederick, Maryland, United States
- [site 12] University of Texas M.D. Anderson Cancer Center - Investigational Cancer Therapeutics
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2016
- Primary completion
- 30 Sept 2023
- Completion
- 30 Sept 2023
- Last update posted
- 9 Nov 2023
- Registered enrollment
- 96
- Registry id
- NCT02718066
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.